Pioneering Cardiac Care: Results from the DCD HEART Trial The DCD HEART Trial has broken new ground in the field of heart transplantation, examining the outcomes with donor hearts after circulatory death—a method that could potentially increase the donor pool … Read More
Page Not Found
RUBY Trial Summary: Dostarlimab for Endometrial Cancer
The RUBY Trial: A New Chapter in Endometrial Cancer Treatment Recent results from the RUBY Trial have introduced a significant advancement in the treatment of primary advanced or recurrent endometrial cancer. The phase 3, randomized, double-blind trial meticulously evaluated the … Read More
BEST Trial Summary: Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass
The BEST Trial: Pioneering Insights into Bariatric Surgery Outcomes The groundbreaking ‘BEST Trial’ (Bariatric Surgery Comparative Trial) has offered a fresh perspective on the effectiveness and safety of two prominent bariatric procedures: Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB). … Read More
ARTESIA Trial: Apixaban for Subclinical AFib
ARTESIA Trial Summary The ARTESIA trial, which stands for “Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation,” was a landmark study aimed at comparing the efficacy and safety of apixaban versus aspirin in patients with subclinical atrial fibrillation (AF). The … Read More
COSMIC-313 Trial: Cabozantinib in Renal Cell Cancer
The COSMIC-313 Trial: A New Frontier in Renal-Cell Carcinoma Treatment In the landscape of oncology, renal-cell carcinoma stands as a formidable challenge, often presenting at advanced stages and with a dire need for effective treatments. Enter the COSMIC-313 Trial, a … Read More
DAPA-MI Trial: Dapagliflozin in MI
DAPA-MI Trial: Dapagliflozin in MI? The DAPA-MI Trial, as reported in the New England Journal of Medicine in 2023, was a randomized, double-blind clinical trial designed to assess the safety and efficacy of dapagliflozin, a medication typically used to treat … Read More
ELATIVE Trial: Elafibranor in PBC
Title: ELATIVE Trial: A Landmark Study on Elafibranor’s Efficacy in Primary Biliary Cholangitis Introduction:The medical community has taken a significant step forward with the recent ELATIVE Trial, a study that rigorously evaluates the efficacy and safety of Elafibranor in patients … Read More
CASTLE HTx Trial: Ablation in HF and AFib
The CASTLE HTx trial, as published in the New England Journal of Medicine in 2023, was a single-center, open-label trial that aimed to determine the potential therapeutic effect of catheter ablation for symptomatic atrial fibrillation (AF) in patients with end-stage … Read More
BEAM-BD Trial: Antidepressants in Bipolar 1 Depression
The BEAM-BD trial, as presented in the New England Journal of Medicine in 2023, was a multisite, double-blind, randomized, placebo-controlled trial with the objective of comparing the maintenance of treatment with adjunctive escitalopram or bupropion XL versus discontinuation of antidepressant … Read More
ADVENT Trial: Pulse Field Ablation for AFib
The ADVENT trial, published in the New England Journal of Medicine in 2023, was a randomized, single-blind, noninferiority trial designed to compare the safety and efficacy of pulsed field ablation with conventional thermal ablation techniques (radiofrequency or cryoballoon) for the … Read More